S&P 500   3,364.84 (-0.45%)
DOW   29,179.06 (-0.75%)
QQQ   234.18 (-0.20%)
AAPL   317.90 (-2.17%)
FB   217.14 (+1.38%)
MSFT   186.47 (+0.60%)
GOOGL   1,517.00 (-0.11%)
AMZN   2,153.60 (+0.88%)
NVDA   293.23 (+1.19%)
BABA   219.01 (-0.28%)
MU   57.66 (-1.44%)
GE   12.78 (-0.39%)
TSLA   849.29 (+6.16%)
AMD   57.18 (+3.38%)
T   38.25 (-0.03%)
ACB   1.63 (+3.15%)
F   8.03 (-0.86%)
NFLX   387.44 (+1.85%)
BAC   34.25 (-1.75%)
DIS   138.43 (-0.80%)
GILD   66.92 (-0.95%)
S&P 500   3,364.84 (-0.45%)
DOW   29,179.06 (-0.75%)
QQQ   234.18 (-0.20%)
AAPL   317.90 (-2.17%)
FB   217.14 (+1.38%)
MSFT   186.47 (+0.60%)
GOOGL   1,517.00 (-0.11%)
AMZN   2,153.60 (+0.88%)
NVDA   293.23 (+1.19%)
BABA   219.01 (-0.28%)
MU   57.66 (-1.44%)
GE   12.78 (-0.39%)
TSLA   849.29 (+6.16%)
AMD   57.18 (+3.38%)
T   38.25 (-0.03%)
ACB   1.63 (+3.15%)
F   8.03 (-0.86%)
NFLX   387.44 (+1.85%)
BAC   34.25 (-1.75%)
DIS   138.43 (-0.80%)
GILD   66.92 (-0.95%)
S&P 500   3,364.84 (-0.45%)
DOW   29,179.06 (-0.75%)
QQQ   234.18 (-0.20%)
AAPL   317.90 (-2.17%)
FB   217.14 (+1.38%)
MSFT   186.47 (+0.60%)
GOOGL   1,517.00 (-0.11%)
AMZN   2,153.60 (+0.88%)
NVDA   293.23 (+1.19%)
BABA   219.01 (-0.28%)
MU   57.66 (-1.44%)
GE   12.78 (-0.39%)
TSLA   849.29 (+6.16%)
AMD   57.18 (+3.38%)
T   38.25 (-0.03%)
ACB   1.63 (+3.15%)
F   8.03 (-0.86%)
NFLX   387.44 (+1.85%)
BAC   34.25 (-1.75%)
DIS   138.43 (-0.80%)
GILD   66.92 (-0.95%)
S&P 500   3,364.84 (-0.45%)
DOW   29,179.06 (-0.75%)
QQQ   234.18 (-0.20%)
AAPL   317.90 (-2.17%)
FB   217.14 (+1.38%)
MSFT   186.47 (+0.60%)
GOOGL   1,517.00 (-0.11%)
AMZN   2,153.60 (+0.88%)
NVDA   293.23 (+1.19%)
BABA   219.01 (-0.28%)
MU   57.66 (-1.44%)
GE   12.78 (-0.39%)
TSLA   849.29 (+6.16%)
AMD   57.18 (+3.38%)
T   38.25 (-0.03%)
ACB   1.63 (+3.15%)
F   8.03 (-0.86%)
NFLX   387.44 (+1.85%)
BAC   34.25 (-1.75%)
DIS   138.43 (-0.80%)
GILD   66.92 (-0.95%)
Log in

Esperion Therapeutics SEC Filings & 10K Form (NASDAQ:ESPR)

$70.82
+0.32 (+0.45 %)
(As of 02/18/2020 02:08 PM ET)
Today's Range
$69.80
Now: $70.82
$72.22
50-Day Range
$49.10
MA: $59.35
$73.84
52-Week Range
$33.13
Now: $70.82
$76.98
Volume42,380 shs
Average Volume728,005 shs
Market Capitalization$1.94 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.13

SEC Filings

Esperion Therapeutics (NASDAQ:ESPR) SEC Filings

DateFilerForm TypeView
01/27/2020
11:51 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:23 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
1:54 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
7:30 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:22 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:09 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
11:42 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:18 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
5:09 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:49 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:32 PM
Esperion Therapeutics (Filer)
Form DEF 14A
04/05/2019
4:23 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:41 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
8:02 AM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
6:50 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:50 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:45 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:22 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
3:30 PM
Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G/A
02/14/2019
10:16 AM
Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/11/2019
1:17 PM
Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
01/07/2019
4:10 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
9:57 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
12/26/2018
10:44 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:07 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
12:14 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:18 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:17 PM
Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:15 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
6:56 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
4:00 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
3:20 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
3:35 PM
Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
10/30/2018
3:33 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Braslyn Ltd. (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Tuesday Thirteen Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2018
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2018
4:05 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
3:56 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
6:15 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
6:18 AM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2018
2:23 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:31 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
6:31 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
10:55 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2018
4:06 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
11:43 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
1:59 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
4:08 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
1:34 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:34 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:34 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2018
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2018
3:18 PM
Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:18 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:16 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:15 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:11 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
7:25 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2018
2:49 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:06 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
05/11/2018
3:16 PM
Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G
05/10/2018
3:22 PM
BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
05/08/2018
6:41 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
6:55 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
3:32 PM
Esperion Therapeutics (Filer)
Form DEF 14A
03/29/2018
6:47 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
6:46 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2018
3:38 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/20/2018
3:37 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/20/2018
3:33 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: S&P 500 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel